With these applications, DNP+ hopes to prevent the US pharma major from obtaining patent rights on sofosbuvir and velpatasvir, which would allow …
With these applications, DNP+ hopes to prevent the US pharma major from obtaining patent rights on sofosbuvir and velpatasvir, which would allow …